BioWorld

June 6, 2003

Millennium Trimming Operations, Staff As Focus Turns To Profits

In announcing a plan to restructure its organization, Millennium Pharmaceuticals Inc. said its goal is to focus on the commercially attractive items in its pipeline and to reach profitability by 2006. (BioWorld Today) Read More

NPS, Enzon End Merger Plans After Failing To Come To Terms

Rare, Unplumbable Contortions Of Dual Sézary Syndrome Malignancy Launch Therapeutic Clinical Trials

Discovery Labs' Surfaxin Support Trial Provides Positive Early Data

Isis, Lilly Rework Agreement For Affinitak Manufacturing

Other News To Note

Today's news in brief

BioWorld

BioWorld briefs for Jan 15, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Jan. 15, 2026.

3D rendering of antibody drug conjugated with cytotoxic payload

ADCs’ breakout 2025 and their still-unfinished potential

BioWorld

Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...

LINC01116 has prognostic value in lung cancer, study shows

BioWorld MedTech

Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...

SERPINB1 as potential biomarker for spinocerebellar ataxia type 2

BioWorld Science

Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...